MARONESE, CARLO ALBERTO
MARONESE, CARLO ALBERTO
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
Effectiveness and safety of Tildrakizumab in elderly and frail elderly psoriatic patients up to 2 years
2025 L. Mastorino, P. Dapavo, M. Burlando, P. Gisondi, C.A. Maronese, A. Ruggiero, M. Galluzzo, M.C. Pisani, L. Sacchelli, G. Caldarola, G. Avallone, A.V. Marzano, M. Megna, E. Campione, F. Loconsole, F. Bardazzi, C. De Simone, P. Quaglino, S. Ribero
Acute generalized exanthematous pustulosis: 15-year retrospective multicenter experience
2025 S. Guida, V. Caputo, A.L. Di Marco, J.W. Schroeder, G. Paolino, I.F. Aromolo, C.A. Maronese, A.V. Marzano, M.T. Fernández Figueras, M. Iglesias-Sancho, E. Bonoldi, F. Rongioletti
Effectiveness of Dupilumab and Omalizumab in Bullous Pemphigoid: A Nationwide Retrospective Cohort Study
2025 G. Avallone, C.A. Maronese, M. Zussino, S. Muratori, S.M. Ferrucci, P. Quaglino, E. Manni, M. Romanelli, C. De Simone, C. Foti, L. Gargiulo, V. Maione, P. Calzavara-Pinton, F. Bardazzi, B.M. Piraccini, E. Antiga, G. Rech, R. Balestri, P. Vezzoli, P. Sena, M. Esposito, M.C. Fargnoli, D. Termini, L. Valtellini, R.R. Satta, C. Vassallo, A. Provini, G. Di Zenzo, A. Campanati, M. Caproni, E. Cozzani, S. Ribero, A.V. Marzano
Successful Treatment of PAPASH Syndrome With Concomitant FMF Using IL-1 Blockade: A Case Report
2025 C. Moltrasio, M. Romagnuolo, C.A. Maronese, M. Carrabba, G. Fabio, A.V. Marzano
Interleukin-13 in immunohistochemistry: implications for Grover disease, morphea, and immune checkpoint inhibitor-induced bullous pemphigoid
2025 I.F. Aromolo, F.L. Boggio, C. Moltrasio, G. Pini, M. Brevi, M. Romagnuolo, C.A. Maronese, A.V. Marzano
Successful treatment of Hailey-Hailey disease with oral roflumilast
2025 G. Genovese, C.A. Maronese, D. Termini, L. Sarno, S. Buffon, F. Derlino, F.L. Boggio, A.V. Marzano
Romosozumab for glucocorticosteroid-induced osteoporosis in patients with autoimmune blistering diseases: primum non nocere
2025 C.A. Maronese, G. Avallone, D. Termini, A.V. Marzano
A unique case of steroid-resistant, giant cellulitis-like Sweet syndrome mimicking alpha-1-antitrypsin deficiency-associated panniculitis: successful treatment with dapsone
2025 C.A. Maronese, G.A. Croci, F. Derlino, I.F. Aromolo, C. Moltrasio, A.V. Marzano
Effectiveness of nanofat in treatment-refractory penile lichen sclerosus: results from a pilot retrospective single-center case series
2025 M. Brambilla, V. Benzecry, C.A. Maronese, F. Barberi, M. Cusini, V. Boero, A.V. Marzano
What is 'chronic' pustular psoriasis? Identifying candidates for long-term subcutaneous spesolimab treatment
2025 A.V. Marzano, C.A. Maronese, A. Balato, A. Costanzo, A. Dattola, M.C. Fargnoli, P. Gisondi, S. Piaserico, F. Prignano
Pyoderma gangrenosum: pathogenetic mechanisms and their implications for treatment
2025 C. Moltrasio, M. Romagnuolo, G. Tavoletti, C.A. Maronese, A.V. Marzano
Yao syndrome: a novel systemic autoinflammatory disease with cutaneous manifestations
2025 M. Shakhashiro, S. Sadeghian, J. Newcomer, A.V. Marzano, C.A. Maronese, J.M. Davis, A. Alavi
Fatal Toxic Epidermal Necrolysis-Like Lupus Erythematosus in a Patient With Metastatic Histiocytic Sarcoma
2025 C.A. Maronese, F. Derlino, D. Termini, S. Buffon, L. Sarno, G. Genovese, F.L. Boggio, A.V. Marzano
Clinicopathological definition, management and prognostic value of mogamulizumab‐associated rash and other cutaneous events: A systematic review
2024 G. Avallone, G. Roccuzzo, A. Pileri, C. Agostinelli, C.A. Maronese, C. Aquino, G. Tavoletti, F. Onida, P. Fava, S. Ribero, A.V. Marzano, E. Berti, P. Quaglino, S. Alberti‐violetti
Association between maternal dupilumab exposure and pregnancy outcomes in patients with moderate-to-severe atopic dermatitis: A nationwide retrospective cohort study
2024 G. Avallone, F. Cavallo, A. Tancredi, C.A. Maronese, M. Bertello, A. Fraghì, C. Conforti, G. Calabrese, M.R. Di Nicola, G.A. Oddenino, L. Gargiulo, N. Gori, C. Loi, P. Romita, V. Piras, L. Bonzano, E. Tolino, G. Paolino, M. Napolitano, C. Patruno, E. Nettis, C. Ferreli, G. Roccuzzo, L. Marozio, M. Silvio, F. Russo, L. Bettolini, R. Gallo, S.R. Mercuri, L. Mastorino, M. Rossi, I. Zalaudek, G. Argenziano, I. Trave, A. Costanzo, A. Chiricozzi, C. Gurioli, C. Foti, C. Potenza, S.M. Ferrucci, A. Balato, A. Parodi, A.V. Marzano, M. Ortoncelli, S. Ribero, P. Quaglino
Identifying candidates for early intervention in hidradenitis suppurativa
2024 C.A. Maronese, A.V. Marzano
Neutrophilic and eosinophilic dermatoses associated with hematological malignancy
2024 C.A. Maronese, F. Derlino, C. Moltrasio, D. Cattaneo, A. Iurlo, A.V. Marzano
IRAK4: A novel target in the therapeutic landscape of hidradenitis suppurativa?
2024 C.A. Maronese, V. Piguet, A.V. Marzano
Anti-IL-17/23 Drugs for the Treatment of Moderate-to-Severe Hidradenitis Suppurativa in Patients With Concomitant Psoriasis: A Multicenter Retrospective Study
2024 L. Gargiulo, L. Ibba, A. Narcisi, S. Giordano, C.A. Maronese, F. Martora, F. Repetto, G. Paolino, A. Balato, M. Burlando, P. Dapavo, V. Dini, C. Guarneri, A.V. Marzano, M. Megna, S.R. Mercuri, A. Costanzo, M. Valenti
Paradoxical Psoriasis: An Updated Review of Clinical Features, Pathogenesis, and Treatment Options
2024 C.A. Maronese, M. Valenti, C. Moltrasio, M. Romagnuolo, S.M. Ferrucci, M. Gilliet, A. Costanzo, A.V. Marzano